SKYE
Skye Bioscience, Inc. · Healthcare · Market cap $57.7M
Insiders sold $889K net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Sep 24, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$889K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 24, 2026
5AM Partners VII, LLC
Skye Bioscience, Inc. (SKYE) has 7 SEC Form 4 filings (31 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 24, 2026.
Inside the rolling window, 2 insiders at Skye Bioscience, Inc. reported no open-market purchases and 12 open-market sales totaling $889K. The most active filer is 10% Owner 5AM Partners VII, LLC with 6 filings. Insiders have net sold $889K over the trailing 6 months. The most recent open-market filing is a sale of 28,700 shares by 10% Owner 5AM Partners VII, LLC, dated Sep 22, 2026, worth $47K.
- Industry:Biotechnology
- CEO:Punit Dhillon
- Employees:12
- HQ:San Diego, CA, US
- IPO:2015-01-06
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Sale | 28,700 | $47K | Sep 24 | -4.1% | SEC ↗ | |
| 10% Owner | Sale | 119,379 | $192K | Sep 24 | -4.1% | SEC ↗ | |
| Director, 10% Owner | Sale | 28,700 | $47K | Sep 24 | -4.1% | SEC ↗ | |
| Director, 10% Owner | Sale | 119,379 | $192K | Sep 24 | -4.1% | SEC ↗ | |
| Director, 10% Owner | Sale | 33,892 | $65K | Sep 18 | -7.6% | SEC ↗ | |
| 10% Owner | Sale | 33,892 | $65K | Sep 18 | — | SEC ↗ | |
Schwab Andrew J.First filing | Director, 10% Owner | Sale | 37,500 | $114K | Aug 20 | — | SEC ↗ |
Schwab Andrew J.First filing | Director, 10% Owner | Sale | 8,518 | $24K | Aug 20 | — | SEC ↗ |
Schwab Andrew J.First filing | Director, 10% Owner | Sale | 963 | $2K | Aug 20 | — | SEC ↗ |
5AM Partners VII, LLCFirst filing | 10% Owner | Sale | 37,500 | $114K | Aug 20 | — | SEC ↗ |
5AM Partners VII, LLCFirst filing | 10% Owner | Sale | 8,518 | $24K | Aug 20 | — | SEC ↗ |
5AM Partners VII, LLCFirst filing | 10% Owner | Sale | 963 | $2K | Aug 20 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does SKYE have?
Skye Bioscience, Inc. (SKYE) has 7 SEC Form 4 filings (31 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 24, 2026.
When was the most recent SEC Form 4 filing for SKYE?
The most recent Form 4 filing for SKYE on Tracefour is dated Sep 24, 2026.
Who is the most active insider at SKYE?
The most active SEC Form 4 filer at SKYE in the rolling window is 10% Owner 5AM Partners VII, LLC, with 6 filings.
What is the net insider flow at SKYE over the last 6 months?
Over the trailing 180 days, insiders at SKYE have net sold $889K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at SKYE in the current window?
Inside the rolling window, insiders at SKYE bought $0 and sold $889K based on SEC Form 4 filings.
Can I get alerts for SKYE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Skye Bioscience, Inc. (SKYE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Skye Bioscience, Inc. is in the Healthcare sector.